Search

Your search keyword '"Yraima, Cordeiro"' showing total 120 results

Search Constraints

Start Over You searched for: Author "Yraima, Cordeiro" Remove constraint Author: "Yraima, Cordeiro"
120 results on '"Yraima, Cordeiro"'

Search Results

1. PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma

2. Rabbit PrP Is Partially Resistant to in vitro Aggregation Induced by Different Biological Cofactors

Catalog

Books, media, physical & digital resources

3. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies

4. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant

5. Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus

6. Diosmin induces caspase-dependent apoptosis in human glioblastoma cells

7. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases

8. Copper drives prion protein phase separation and modulates aggregation

9. Toxicological Evaluation of Anti-Scrapie Trimethoxychalcones and Oxadiazoles

11. In Vitro Characterization of Protein:Nucleic Acid Liquid-Liquid Phase Separation by Microscopy Methods and Nanoparticle Tracking Analysis

13. New mescaline-related N-acylhydrazone and its unsubstituted benzoyl derivative: Promising metallophores for copper-associated deleterious effects relief in Alzheimer's disease

14. Phase separation of the mammalian prion protein: Physiological and pathological perspectives

15. Intrinsic disorder and phase transitions: Pieces in the puzzling role of the prion protein in health and disease

17. Biophysical Studies on BEX3, the p75NTR-Associated Cell Death Executor, Reveal a High-Order Oligomer with Partially Folded Regions.

18. Liquid‐liquid phase separation and fibrillation of the prion protein modulated by a high‐affinity DNA aptamer

19. Synthesis and in silico and in vitro evaluation of trimethoxy-benzamides designed as anti-prion derivatives

20. RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction

21. Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands

23. Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches.

24. Intrinsic disorder and phase transitions: Pieces in the puzzling role of the prion protein in health and disease

25. Accommodation of In-Register N-Linked Glycans on Prion Protein Amyloid Cores

26. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies

27. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells

28. Nucleic acid actions on abnormal protein aggregation, phase transitions and phase separation

29. Moniliophthora perniciosa necrosis- and ethylene-inducing protein 2 (MpNep2) as a metastable dimer in solution: structural and functional implications.

30. Prion protein complexed to a DNA aptamer induce behavioral and synapse dysfunction in mice

31. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases

32. Phase Separation and Disorder-to-Order Transition of Human Brain Expressed X-Linked 3 (hBEX3) in the Presence of Small Fragments of tRNA

33. Liquid-liquid phase separation and aggregation of the prion protein globular domain modulated by a high-affinity DNA aptamer

34. Nanoencapsulated Lecitase Ultra and Thermomyces lanuginosus Lipase, a Comparative Structural Study

35. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant

36. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases

37. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location

39. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids

40. The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin

41. Heparin binding confers prion stability and impairs its aggregation

42. Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases

43. The effect of temperature on protein refolding at high pressure: Enhanced green fluorescent protein as a model

44. Conformational dissection of Thermomyces lanuginosus lipase in solution

45. Pressure–temperature folding landscape in proteins involved in neurodegenerative diseases and cancer

46. Kinetics and mechanism of lipase catalyzed monoacylglycerols synthesis

47. Mammalian prion amyloid formation in bacteria

48. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain

49. The 'Jekyll and Hyde' Actions of Nucleic Acids on the Prion-like Aggregation of Proteins

50. Insights into the Intramolecular Coupling between the N- and C-Domains of Troponin C Derived from High-Pressure, Fluorescence, Nuclear Magnetic Resonance, and Small-Angle X-ray Scattering Studies